Work

ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23

Year: 2006

Type: article

Source: Nature Immunology

DOI: 10.1038/ni1399

Authors: Gisela Weskamp, Jill W Ford, Jamie Sturgill, Steve Martin, Andrew J P Docherty, Steven Swendeman, Neil Broadway, Dieter Hartmann, Paul Saftig, Shelby Umland, Atsuko Sehara-Fujisawa, Roy A Black, Andreas Ludwig, J David Becherer, Daniel H Conrad, Carl P Blobel

Institutions: Hospital for Special Surgery, Cornell University, Weill Cornell Medicine, Virginia Commonwealth University, GlaxoSmithKline (United Kingdom), UCB Pharma (United Kingdom), Vlaams Instituut voor Biotechnologie, KU Leuven, Christian-Albrechts-Universität zu Kiel, Kyoto University, Amgen (United States), RWTH Aachen University, GlaxoSmithKline (United States)

Language: English

Topic: Protease and Inhibitor Mechanisms

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: Structure and Function of the B Lymphocyte FCe Receptor, G1714883407, EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION, iRhoms 1 and 2: Key regulators of ADAM17-dependent EGFR signaling, Training in Hypersensitivity and Cancer Immunology

OpenAlex ID: W2147110025

FWCI: 5.459

Cites: 47

Cited by: 215

Related to: 9